Edition:
United Kingdom

Seikagaku Corp (4548.T)

4548.T on Tokyo Stock Exchange

1,619JPY
17 Nov 2017
Change (% chg)

¥-5 (-0.31%)
Prev Close
¥1,624
Open
¥1,638
Day's High
¥1,651
Day's Low
¥1,610
Volume
203,200
Avg. Vol
127,328
52-wk High
¥2,109
52-wk Low
¥1,526

Chart for

About

SEIKAGAKU CORPORATION is principally engaged in the research, development, purchase, manufacture and sale of pharmaceutical products and limulus amebocyte lysate (LAL). The Company operates in two business segments. The Pharmaceutical business segment provides hyaluronan-based medicines for joint function improvement, ophthalmic... (more)
No analyst recommendations are available for .

Overall

Beta: 0.70
Market Cap(Mil.): ¥114,025.90
Shares Outstanding(Mil.): 56.81
Dividend: 13.00
Yield (%): 1.30

Financials

  Industry Sector
P/E (TTM): -- 31.15 16.44
EPS (TTM): -- -- --
ROI: -- 14.99 10.62
ROE: -- 16.33 14.20

BRIEF-Ribomic signs collaborative research contract with SEIKAGAKU

* Says it signed collaborative research contract with SEIKAGAKU CORPORATION

08 Nov 2017

BRIEF- Seikagaku initiates phase II study of SI-613 for treatment of knee osteoarthritis in U.S.

* Says it announces the start of phase II study of SI-613 in patients with osteoarthritis of the knee, in the U.S.

16 Jun 2017

Earnings vs. Estimates